Search

everythinglearnresearchcommunity

for

Search:↓

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Majocchi's granuloma can occur in kidney transplant patients on tacrolimus and can be treated with antifungal medication.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Children with frequent severe infections and low antibodies should be checked for immune deficiencies.

A rare genetic mutation caused unusual skin symptoms in a man with Blau syndrome.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

A three-year-old girl survived a rare serious infection caused by BCG vaccination, which improved after treatment with a leprosy drug.

Monoclonal antibodies are often linked to alopecia areata cases.

Belimumab may cause hair loss in lupus patients.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Psoriasis or contact dermatitis can override alopecia areata, allowing hair growth.

The treatment is safe and shows promise for metastatic breast cancer.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Many patients in the rheumatology clinic adjusted or stopped their medications due to side effects.

Abatacept may help some people with alopecia areata regrow hair.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

Controlled microflora in animals delays immune cell maturation and affects immunity.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.